All In Biotech

Drug Trial Radar · NCT06104319

Dose Exploration Study of GSK4532990 in. Participants With NASH or Suspected NASH

A Phase 2a, Single Dose, Open-label, Dose Exploration Study to Assess the PK-PD Activity, Safety, and Tolerability of GSK4532990 in Adult. Participants With NASH or Suspected NASH

Last checked: Nov 20, 2026Latest source record: Oct 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

61

Actual

Start

Jan 22, 2024

Primary completion

Sep 23, 2025

Study completion Sep 23, 2025

Sponsor

Lead sponsor
GlaxoSmithKlineGSK (GSK)
Sponsor type
Industry
First posted
Oct 27, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to understand how the drug GSK4532990 is processed in the body (pharmacokinetics) and how it works in the liver (pharmacodynamics) as well as to ensure it is safe and well-tolerated. The total study duration for each participant will be approximately 24-36 weeks.

Conditions

  • Non-alcoholic Fatty Liver Disease

Interventions

  • GSK4532990Drug

    GSK4532990 will be administered

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Predicted Mean Percent Change From Baseline (CFB) in Liver Biopsy-derived HSD17B13 Protein Expression LevelsTime frame: Baseline (Day 1), At weeks 8, 12 and 28
  2. Predicted Mean Percent Change From Baseline (CFB) in Liver Biopsy-derived HSD17B13 mRNA Expression LevelsTime frame: Baseline (Day 1), At weeks 8, 12 and 28

Locations

14 sites in 1 country. Site status is shown where the registry gives one.

  • GSK Investigational Site

    Chula Vista, California

  • GSK Investigational Site

    Montclair, California

  • GSK Investigational Site

    San Diego, California

  • GSK Investigational Site

    San Diego, California

  • GSK Investigational Site

    Brandon, Florida

  • GSK Investigational Site

    Miami, Florida

  • GSK Investigational Site

    Miami, Florida

  • GSK Investigational Site

    Miami Lakes, Florida

  • GSK Investigational Site

    Indianapolis, Indiana

  • GSK Investigational Site

    El Dorado, Kansas

  • GSK Investigational Site

    Marrero, Louisiana

  • GSK Investigational Site

    Austin, Texas

  • GSK Investigational Site

    San Antonio, Texas

  • GSK Investigational Site

    San Antonio, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.